The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease

被引:6
作者
Hurley, SF
Scollo, MM
Younie, SJ
English, DR
Swanson, MG
机构
[1] Bainbridge Consultants, Fitzroy, Vic 3068, Australia
[2] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia
[3] Canc Council Victoria, VicHlth Ctr Tobacco Control, Carlton, Vic, Australia
[4] NatlHeart Fdn Australia, Western Australian Div, Subiaco, WA, Australia
关键词
D O I
10.5694/j.1326-5377.2004.tb06263.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate Pharmaceutical Benefits Scheme (PBS) subsidies for drugs to treat smoking-related cardiovascular disease (CVD) in 2001-02, and over the period of the government's Intergenerational Report (IGR), assuming current smoking prevalence rates and a 5% absolute reduction. Design and setting: An Australian epidemiological study, using prescribing data, aetiological fraction methodology, and IGR trends. Main outcome measures: Estimated smoking-related PBS subsidy costs in 2001-02 and predicted cumulative subsidies until 2041-42, under current and reduced smoking prevalence assumptions. Results: The PBS costs of smoking-related CVD in 2001-02 were $126 million, 9.77% of the cost of drugs for CVD and 2.96% of total PBS subsidies. The cumulative difference in these costs over the 40-year period with a 5% drop in smoking prevalence was predicted to be $4.5 billion, a 17% reduction. The saving would be $1.14 billion discounting future costs at 5% per year. Conclusions: Further investment in tobacco control interventions could curb the increasing cost of the PBS and contribute to government efforts to ensure the viability of Australia's healthcare-financing programs. The net present value of a campaign to reduce smoking prevalence was estimated at $1 billion, with an internal rate of return of 33%.
引用
收藏
页码:252 / 255
页数:4
相关论文
共 17 条
[1]  
*AIHW GP STAT CLAS, 2002, SAND ABSTRACT 30 BEA
[2]  
[Anonymous], CURB EP GOV EC TOB C
[3]  
[Anonymous], 5 COMM AUSTR
[4]  
*AUSTR I HLTH WELF, 2001, DRUG STAT SER AIHW, V11
[5]   Impact of the Massachusetts tobacco control programme: population based trend analysis [J].
Biener, L ;
Harris, JE ;
Hamilton, W .
BRITISH MEDICAL JOURNAL, 2000, 321 (7257) :351-354
[6]  
BRITT H, 2001, GEN PRACTICE SERIES, V8
[7]  
CARTER R, 2000, AUSTR NATL TOBACCO C, P201
[8]  
*COMM DEP HLTH AG, 2003, APPL EC RET INV PUBL
[9]   MORTALITY IN RELATION TO SMOKING - 40 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS [J].
DOLL, R ;
PETO, R ;
WHEATLEY, K ;
GRAY, R ;
SUTHERLAND, I .
BRITISH MEDICAL JOURNAL, 1994, 309 (6959) :901-911
[10]   The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
Cameron, AJ ;
Shaw, J ;
de Courten, M ;
Jolley, D ;
McCarty, DJ .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) :119-129